Impressive lipid changes following hypolipidaemic drug administration can unveil subclinical hyperthyroidism

Authors
Liberopoulos, E Miltiadous, G Elisaf, M
Citation
E. Liberopoulos et al., Impressive lipid changes following hypolipidaemic drug administration can unveil subclinical hyperthyroidism, DIABET OB M, 3(2), 2001, pp. 97-98
Citations number
10
Categorie Soggetti
Endocrynology, Metabolism & Nutrition
Journal title
DIABETES OBESITY & METABOLISM
ISSN journal
14628902 → ACNP
Volume
3
Issue
2
Year of publication
2001
Pages
97 - 98
Database
ISI
SICI code
1462-8902(200104)3:2<97:ILCFHD>2.0.ZU;2-0
Abstract
It is well known that thyroid hormones modulate lipoprotein metabolism. Thu s, the presence of clinical or subclinical hyperthyroidism may influence li pid parameters of dyslipidaemic patients and the efficacy of hypolipidaemic therapy. Here we present a patient with mixed hyperlipidaemia whose impres sive improvement of his lipid profile following ciprofibrate administration pointed towards the diagnosis of asymptomatic underlying subclinical hyper thyroidism.